About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news of 2025. We meticulously curate and categorize the latest collaborations and M&A activities, ensuring you ...

(2) Method and Place of Return of Share Certificates, etc. The tender offer agent will return the necessary share certificates, etc. to the state at the time of tendering in the tendering ...

SPARTANBURG COUNTY, S.C. (WSPA) – A biotech research and development center announced that they have plans to set up operations in Spartanburg County. Related video: $19M childcare campus coming ...

Virtus BBC ETF fell 9.74% to $17.15; SPDR XBI ETF dropped 6.63% to $77.17 on Tuesday. William Blair says Moderna faces increased scrutiny with mRNA vaccines under new CBER leadership. Discover the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Vinay Prasad's appointment as CBER director has caused biotech stocks to fall due to concerns over potential regulatory changes. Prasad's history of criticizing FDA decisions suggests possible ...

Sarepta, other biotech stocks tumble as FDA appoints new CBER director ...

Boston Children’s pauses move into Fenway lab building New Cambridge biotech wants to stop disease before it starts New Cambridge biotech wants to stop disease before it starts Thermo Fisher ...

Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing its first drug asset from the deal. Lilly will pay up to $415 million in ...